In healthcare transactions, the word "partnership" gets used early and often. It usually shows up in the first meeting, the first deck, and the first term sheet conversation.

It is also one of the most common sources of disappointment after close.

This is one of the predictable friction points in MSO partnerships: the gap between expectation and reality. Not because anyone necessarily lied, but because more often than not, both sides used the same word while meaning different things. One definition was relational and the other was structural. If that gap is not closed before signing, it tends to reopen later as conflict over autonomy, decision rights, and what changes are allowed.

A durable partnership requires a shared definition that can survive real operations.

Two Meanings People Use

For many physicians, especially founders and senior clinicians, "partnership" means respect for clinical judgment, a meaningful seat at the table, no surprises, changes discussed before they happen, and a sense that the practice will remain recognizable after the transaction. This definition is rooted in professional norms: peer treatment, seniority, and trust.

For an MSO, "partnership" is primarily expressed through agreements and operating rules. It means what services the MSO provides, what authority the MSO holds over non-clinical operations, how fees are calculated and adjusted, what decisions require physician input, and how disputes are handled when people disagree. This definition is about what the documents say will happen when a decision needs to be made on an ordinary Tuesday morning.

Conflict typically starts when someone tries to solve a structural issue using a relational expectation. If a physician assumes a decision will be discussed "because we are partners," but the agreements grant the MSO authority to implement that change, the physician experiences it as a breach while the MSO experiences it as execution. Both can be acting normally, and the relationship still fractures.

Translate Expectations Into Writing Before You Sign

The goal of a good diligence process is not to lawyer everything to death. It is to translate the real expectations into language that can be executed.

In New York, CPOM constraints generally require a clear separation between clinical decision-making and non-clinical management. That provides an important compliance frame, but it does not automatically remove ambiguity. A CPOM-compliant structure can still create stress if the day-to-day boundaries are not explicit. The question physicians should ask is whether both sides agree, specifically, on who decides what and how changes get made.

How to Test What "Partnership" Actually Means

If you want to know what partnership actually means in a proposed arrangement, there are six practical questions that will tell you. If the answers are vague, future friction is predictable.

The first is who controls clinical decisions and where is it stated. Clinical autonomy should be a documented fact, not a verbal assurance. Physicians should confirm that clinical judgment, supervision, credentialing, protocols, and quality standards remain controlled by physicians, and that operational metrics do not indirectly override clinical standards.

The second is what services the MSO provides and how scope is defined. A management fee only makes sense if it corresponds to real services. The services list should be specific: staffing administration, payroll and benefits, billing operations support, equipment purchasing and maintenance, scheduling systems, call center workflows, marketing operations, vendor management, facilities support, technology systems, reporting, and other non-clinical functions. If the scope is described as "comprehensive," ask for a detailed service schedule. You need to know exactly what deliverables the management fee is buying.

The third is how fees are set and how they can adjust. Fee predictability is a major driver of stability. Physicians should understand whether fees are fixed, a percentage, cost-based, or a hybrid, and what triggers an increase. If fees can change, the adjustment logic should be tied to scope change such as more locations, more services, or more staffing complexity, not clinical volume.

The fourth is what the governance model looks like and who decides what. This is where the partnership becomes real. Physicians should be able to point to a clear governance process that answers which decisions are physician-controlled, which are MSO-controlled, which are joint decisions, and what happens when there is disagreement. If governance is informal or based on "we will figure it out," the structure is fragile.

The fifth is what changes in year one and how that is documented. Many post-close disputes are about surprise. If the MSO plans to change systems such as billing workflows, scheduling tools, payroll, marketing programs, vendor stack, or staffing workflows, the general year one plan should be disclosed and agreed to before signing. A useful question is what will look different 90 days after close. If no one can answer that, the partnership is relying on trust instead of clarity.

The sixth is what happens in conflict, including dispute resolution and exits. Every partnership is easy when revenue is up and operations are calm. The structure is tested when something goes sideways. Physicians should understand how disputes are escalated before they become legal, whether there is a defined resolution process, and what the unwind or exit options are if alignment breaks. A structure that assumes permanent harmony is usually not durable.

Why Boring Is Better

Many physicians focus on the exciting part of a transaction: valuation, growth plans, expansion opportunities, or new resources. But long-term stability is usually determined by the boring parts: documented boundaries, governance cadence, scope clarity, and predictable change management.

When expectations are written down, they become predictable. Predictability reduces stress and prevents people from renegotiating the relationship every time something changes.

High-functioning MSO partnerships operate on clear rails. When lanes are clear, the model becomes uneventful, and uneventful is what you want.

How Verdira Approaches This

Clinical decisions remain with physicians. MSO scope is clearly defined in writing and tied to real services. Governance is clarified before signing so expectations remain stable after close. We build long-duration platforms and do not operate on forced exits.

If you are evaluating an MSO partnership or successor role and want to sanity-check structure and expectations, we are open to thoughtful conversations.

This article is for general educational purposes and is not legal advice.

Verdira is a healthcare acquisition platform focused on ophthalmology practices. Physician ownership. Transparent structure. No volume quotas. If you're looking for a different model, or you know a colleague who is, contact us today.

Contact info@verdira.com 307-381-3734 verdira.com